Can venetoclax be used to treat multiple myeloma (MM)?

Philippe Moreau, MD, from the University Hospital of Nantes, Nantes, France, speaks about the potential of venetoclax in multiple myeloma (MM) treatment at the 2017 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France. He discusses the current indications of this drug, and highlights that venetoclax is particularly effective in myeloma patients with the t(11,14) translocation. Prof. Moreau describes combination therapies including venetoclax, and speaks about the importance of further trials to determine the efficacy of venetoclax in different patient groups.

Share this video